Abstract
Guttae atenolol 4% (Tenormin), a pure beta1-blocking (i.e., cardioselective) drug, produced a median overall fall of 5-6 mmHg (range 3-2 to 13-2 mmHg) in the first tonometrised eyes of 7 patients with open-angle glaucoma or ocular hypertension and 1 with closed-angle glaucoma (off any treatment for the whole of the day preceding each test day) after allowance for an 'effect' of guttae saline 0-9%, in a double-masked, cross-over trial. By a Wilcoxon matched pairs rank test this was significant at the P less than 0-05 level. The median overall fall of 3-5 mmHg (range 0-8 to 10-8 mmHg) in the second-tonometrised eyes of 7 patients (1 of the 8 contributed only 1 eye) was also significant (P less than 0-05). In 2 patients who had been treated with guttae atenolol 4% daily 3 X for 1 and 2 months there is evidence that, on replacing the atenolol 4% with saline 0-9%, a rise of pressure of around 3 mmHg occurred 2 and 3 and 5 days later, i.e., the drug still retained its effectivity (slightly reduced) after 1 and 2 months.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonomi I., Steindler P. Effect of pindolol on intraocular pressure. Br J Ophthalmol. 1975 Jun;59(6):301–303. doi: 10.1136/bjo.59.6.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elliot M. J., Cullen P. M., Phillips C. I. Ocular hypotensive effect of atenolol (Tenormin, I.C.I.). A new beta-adrenergic blocker. Br J Ophthalmol. 1975 Jun;59(6):296–300. doi: 10.1136/bjo.59.6.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Musini A., Fabbri B., Bergamaschi M., Mandelli V., Shanks R. G. Comparison of the effect of propranolol, lignocaine, and other drugs on normal and raised intraocular pressure in man. Am J Ophthalmol. 1971 Oct;72(4):773–781. doi: 10.1016/0002-9394(71)90017-1. [DOI] [PubMed] [Google Scholar]
- Paterson G. D., Paterson G. A comparison of the ocular hypotensive actions of salbutamol and adrenaline in chronic simple glaucoma. Postgrad Med J. 1971 Mar;47(Suppl):122–124. [PubMed] [Google Scholar]
- Phillips C. I., Macdonald M., Gore S. M., Cullen P. M. Atenolol eye drops. Br Med J. 1976 Dec 11;2(6049):1448–1448. doi: 10.1136/bmj.2.6049.1448-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pollack I. P., Rossi H. Norepinephrine in treatment of ocular hypertension and glaucoma. Arch Ophthalmol. 1975 Mar;93(3):173–177. doi: 10.1001/archopht.1975.01010020181002. [DOI] [PubMed] [Google Scholar]
- Vale J., Gibbs A. C., Phillips C. I. Topical propranolol and ocular tension in the human. Br J Ophthalmol. 1972 Oct;56(10):770–775. doi: 10.1136/bjo.56.10.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vale J., Phillips C. I. Practolol (Eraldin) eye drops as an ocular hypotensive agent. Br J Ophthalmol. 1973 Mar;57(3):210–214. doi: 10.1136/bjo.57.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wettrell K., Pandolfi M. Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers. Exp Eye Res. 1975 Nov;21(5):451–456. doi: 10.1016/0014-4835(75)90126-8. [DOI] [PubMed] [Google Scholar]